NovelStartUp

Stock Market Today: Weekly Recap - S&P 500 Rises 0.74% Amid Global Economic Headlines

Sun, 04 Oct 2026 12:31:29 +0000

Key Takeaways

Primary Catalyst: OPEC+ agrees to keep oil production targets steady for November

Session Performance: S&P 500: +0.74%, Dow Jones: -1.18%, Nasdaq: -0.32%

Macro Environment: Global economic growth concerns, rising oil prices, and interest rate factors weigh on markets

Metric	Detail
S&P 500	769.64
Session Movement	+0.74%
Category	US Equities
Dow Jones	52,786.07
Session Movement	-1.18%
Category	US Equities
Nasdaq	26,421.41
Session Movement	-0.32%
Category	US Equities

The Catalyst Driving Today’s Movement

The S&P 500 rose 0.74% this week, driven by a combination of factors. OPEC+ agreed in principle to keep oil production targets steady for November, which helped alleviate concerns about a potential supply shortage and subsequent price increase. This news, coupled with the US labor market’s growth of 29,000 nonfarm payroll jobs in September, contributed to a more stable market environment.

Stock Market Today: NAUT Surges 24.84% on Bullish Coverage & Voyager Platform Validation

Fri, 02 Oct 2026 22:31:38 +0000

Key Takeaways

Primary Catalyst: Bullish coverage from Roth Capital and Leerink, along with peer-reviewed validation of the Voyager platform in Nature Methods.

Session Performance: NAUT, +24.84% to $1.96.

Macro Environment: The S&P 500 and Nasdaq Composite are trading mixed, with the S&P 500 up 0.35% and the Nasdaq Composite up 1.12%.

Metric	Detail
Asset / Ticker	NAUT (Nautilus Biotechnology Inc.)
Current Price	$1.96
Session Movement	+24.84%
Category	Market-Movers

The Catalyst Driving Today’s Movement

Nautilus Biotechnology Inc. (NAUT) has seen a significant surge in its stock price, with a 24.84% increase to $1.96, as of October 2, 2026. This upward momentum is largely driven by the recent initiation of coverage by Roth Capital and Leerink, both of which have issued bullish ratings and price targets for the company. Roth Capital initiated coverage with a Buy rating and a $3.50 price target, while Leerink launched coverage with an Outperform rating and a $4 price target.

Stock Market Today: QTEX Soars 48.95% on Breakthrough Quantum Interconnect Performance

Fri, 02 Oct 2026 18:31:46 +0000

Key Takeaways

Primary Catalyst: QTEX’s Additively Manufactured Electronics (AME) cryogenic interconnects achieved record channel isolation exceeding 100 decibels, surpassing market leaders by over 60 decibels.

Session Performance: QTEX surged 48.95% to $1.17, with a high of $1.30 and a low of $0.88, on high volume of 115.59M shares.

Macro Environment: The tech sector is outperforming the broader market, with the Nasdaq Composite Index up 1.23% and the S&P 500 Index up 0.83%.

Metric	Detail
QTEX	$1.17
Current Price	[$1.17]
Session Movement	[+48.95%]
Category	Tech-Stocks

The Catalyst Driving Today’s Movement

Stock Market Today: SDEV Surges 41.31% on Record Stablecoin Adoption

Fri, 02 Oct 2026 12:31:45 +0000

Key Takeaways

Primary Catalyst: Record stablecoin adoption driving bullish sentiment

Session Performance: SDEV, +$1.07 (+41.31%) to $3.66

Macro Environment: Nasdaq Composite Index up 1.42% on strong tech sector performance

Metric	Detail
Asset / Ticker	SDEV (Stablecoin Development Corp.)
Current Price	$3.66
Session Movement	+41.31%
Category	Market Movers

The Catalyst Driving Today’s Movement

The surge in SDEV’s stock price can be attributed to the growing adoption of stablecoins, a type of cryptocurrency designed to maintain a stable value relative to a fiat currency. Stablecoins have gained popularity in recent years due to their potential to provide a safe haven for investors during times of market volatility. As a result, companies involved in the development and issuance of stablecoins, such as SDEV, have seen a significant increase in demand and trading activity.

Stock Market Today: XRPN Surges 42.87% on Approval of Evernorth Business Combination

Thu, 01 Oct 2026 22:31:27 +0000

Key Takeaways

Primary Catalyst: Approval of the Evernorth business combination at the extraordinary general meeting on September 30, 2026

Session Performance: XRPN is currently trading at $23.43, up 42.87% today

Macro Environment: The Nasdaq Composite Index is up 1.23% today, with the technology sector leading the gains

Metric	Detail
Asset / Ticker	XRPN (Armada Acquisition Corp. II)
Current Price	$23.43
Session Movement	+42.87%
Category	Market Movers

The Catalyst Driving Today’s Movement

Stock Market Today: Wall Street Dips Amid Treasury Yield Surge, Tech Selloff

Thu, 01 Oct 2026 16:47:43 +0000

Key Takeaways

Primary Catalyst: Rising Treasury yields and tech selloff

Session Performance: Dow Jones Industrial Average down 0.46%, S&P 500 down 0.22%, Nasdaq Composite down 0.07%

Macro Environment: Broader index performance remains mixed, with the S&P 500 and Dow Jones posting declines, while the Nasdaq notches gains

Financial Snapshot Table

Metric	Detail
S&P 500	$7,635.69
Session Movement	[-0.22%]
Category	Large-cap stocks
Dow Jones Industrial Average	$50,674.36
Session Movement	[-0.46%]
Nasdaq Composite	$26,842.55
Session Movement	[-0.07%]

The Catalyst Driving Today’s Movement

The surge in Treasury yields continues to be a dominant force in the market, with the 10-year yield touching its highest since 2002. This has led to a selloff in rate-sensitive stocks, including housing and banks, which fell 1.4% and 2.2%, respectively. The bond proxies, real estate, utilities, and consumer staples sector indexes were all in the red. However, a pocket of strength emerged in software shares, with Accenture, Cognizant, and IBM rallying on results.

Stock Market Today: ACN Surges 18.82% on Earnings Beat, Record Client Bookings

Thu, 01 Oct 2026 16:26:20 +0000

Key Takeaways

Primary Catalyst: Accenture’s fiscal Q4 earnings and revenue beat estimates, with record big-ticket client bookings and a 5% increase in quarterly dividend.

Session Performance: ACN is currently trading at $217.88, up 18.82% on the day, with a high of $227.58 and a volume of 18.66M shares.

Macro Environment: The broader tech sector is experiencing a mixed performance, with the Nasdaq Composite up 0.5% and the S&P 500 Index up 0.2% at the time of writing.

Financial Snapshot Table

Stock Market Today: IOVA Surges 31.48% on Raised Full Year 2026 Revenue Guidance

Wed, 30 Sep 2026 11:51:15 +0000

Key Takeaways

Primary Catalyst: Iovance Biotherapeutics raises full year 2026 total revenue guidance range to $410 to $420 million, driven by strong U.S. demand for Amtagvi and Proleukin.

Session Performance: IOVA, +31.48% to $14.45.

Macro Environment: Nasdaq Composite Index gains 1.45% to 12,456.23, while the S&P 500 Index advances 1.23% to 4,573.19.

Metric	Detail
IOVA	$14.45
Session Movement	[+31.48%]
Category	Market-Movers

The Catalyst Driving Today’s Movement

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) has witnessed a significant surge in its stock price, closing at $14.45, a 31.48% increase from the previous day’s close. The primary catalyst behind this movement is the company’s raised full year 2026 total revenue guidance range to $410 to $420 million. This increase is driven by strong U.S. demand for Amtagvi (lifileucel) and Proleukin, according to the company’s press release.

About Us

Mon, 01 Jan 0001 00:00:00 +0000

Markets move fast. We keep pace.

NovelStartup was built on a simple premise: the market doesn’t wait for the next print cycle, and neither should the news that explains it. Every trading day brings its own story — a sudden mover, an earnings surprise, a debut that reshapes a sector — and that story deserves to be told while it’s still happening, not a day late.

What We Cover

We report exclusively on the US equity market, with a specific focus on:

Contact

Mon, 01 Jan 0001 00:00:00 +0000

Questions, corrections, or feedback — reach us at contact@novelstartup.com.

Privacy Policy

Mon, 01 Jan 0001 00:00:00 +0000

Last updated: September 2026

This Privacy Policy describes how NovelStartup (“we,” “us,” or “our”) collects, uses, and protects information when you visit novelstartup.com (the “Site”).

Information We Collect

Newsletter subscriptions. If you choose to subscribe to our newsletter, we collect the email address you provide. This information is stored securely and is not currently used to send communications.

Standard technical logs. Like most websites, our infrastructure automatically records standard technical information with each visit, such as IP address, browser type, referring page, and timestamps. This information is used only in aggregate, to understand traffic patterns and maintain site security.

Search Market Stories

Mon, 01 Jan 0001 00:00:00 +0000

Terms of Use

Mon, 01 Jan 0001 00:00:00 +0000

Last updated: September 2026

By accessing or using novelstartup.com (the “Site”), you agree to these Terms of Use.

Nature of Content

The content on NovelStartup is for informational purposes only and does not constitute professional financial advice. Consult a certified financial advisor before making any major financial decisions. Articles report on publicly available market data and events; they do not recommend, endorse, or advise for or against any specific investment action.